Changes in Index of Microcirculatory Resistance during PCI in the Left Anterior Descending Coronary Artery in Relation to Total Length of Implanted Stents

Table 1

Baseline characteristics.

Age, years (s.d.)	65.3 (8.2)
Female gender, n (%)	7 (17)
Diabetes mellitus, n (%)	7 (17)
Previous myocardial infarction, n (%)	5 (12)
Previous PCI, n (%)	9 (21)
Atrial flutter, n (%)	2 (5)
Smoking, n (%)
Never	24 (57)
Previous	13 (31)
Smoker	5 (12)
Canadian Cardiovascular Society grade, n (%)
I	15 (36)
II	23 (55)
III	3 (7)
IV	1 (2)
Body mass index (kg/m^2), median (IQR)	27 (24–30)
Total cholesterol (mmol/L), median (IQR)	4.3 (3.7–5.1)
Low density lipoprotein cholesterol (mmol), median (IQR)	2.4 (1.9–3.1)
HbA1c (mmol/mol), median (IQR)	39 (35–42)
Creatinine clearance (mL/min/1.73 m^2), median (IQR)	82 (69–96)
Medication at inclusion
Aspirin	42 (100)
Clopidogrel	40 (95)
Ticagrelor	2 (5)
AII-receptor antagonists, n (%)	12 (29)
Beta-blockers, n (%)	26 (62)
Nitrates, n (%)	10 (24)
Calcium antagonists, n (%)	13 (31)
ACE inhibitors, n (%)	9 (21)
Lipid-lowering therapy at admission	32 (76)

IQR = interquartile range.